Bayer researchers Céline Zimmerli (left) and Dr. Catherine Baillon check the growth of young wheat plants at the wheat breeding station in Milly-la-Forêt, south of Paris, France. (Photo)

Bayer Posts Strong Earnings Growth

Q3

More in the Management Report
Download Full Report (PDF, 3.6MB) Financial Report Newsletter Event Reminder Investor Conference Call Share

Bayer researchers Céline Zimmerli (left) and Dr. Catherine Baillon check the growth of young wheat plants at the wheat breeding station in Milly-la-Forêt, south of Paris, France.

Selected Key Figures

  • Sales

    Key figure Sales (bar chart)Key figure Sales (bar chart) Inactive key figure Sales (bar chart)Inactive key figure Sales (bar chart)

  • EBITDA Before Special Items

    Key figure EBITDA margin (bar chart)Key figure EBITDA margin (bar chart) Inactive key figure EBITDA margin (bar chart)Inactive key figure EBITDA margin (bar chart)

  • Net income

    Key figure Net income (bar chart)Key figure Net income (bar chart) Inactive key figure Net income (bar chart)Inactive key figure Net income (bar chart)

+10,7%

In the third quarter of 2015, Group sales increased by 10.7 percent (reported) and 1.9 percent (currency- and portfolio-adjusted) to EUR 11,036 million.

View all Q3 key figures

+27,6%

Bayer improved EBITDA before special items by 27.6 percent to EUR 2,523 million.

View all Q3 key figures

+20,9%

Net income grew by 20.9 percent to around EUR 1 billion.

View all Q3 key figures

Business Development

Pharmaceuticals Segment

Sales of our Pharmaceuticals segment rose by a substantial 11.7 percent (currency- and portfolio-adjusted) to €3,482 million in the third quarter of 2015. This is largely attributable to the good development of our recently launched products.

Find out more

Consumer Health Segment

Sales of the Consumer Health segment increased by 2.2 percent (currency- and portfolio-adjusted) in the third quarter of 2015 to €2,169 million, with all divisions contributing to this growth.

Find out more

CropScience Subgroup

Sales of the CropScience subgroup in the third quarter of 2015, at €2,113 million, were slightly above the strong prior-year period (currency- and portfolio-adjusted: +1.6percent; reported: +9.5 percent).

Find out more